<SEC-DOCUMENT>0000920465-20-000160-index.html : 20201202 <SEC-HEADER>0000920465-20-000160.hdr.sgml : 20201202 <ACCEPTANCE-DATETIME>20201202162127 ACCESSION NUMBER: 0000920465-20-000160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20201202 DATE AS OF CHANGE: 20201202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hearne Michael S CENTRAL INDEX KEY: 0001759910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 201364022 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>wf-form4_160694407414311.xml <DESCRIPTION>FORM 4 <TEXT> Document 1 - file: wf-form4_160694407414311.html
Document 1 - RAW XML: wf-form4_160694407414311.xml
</DOCUMENT> </SEC-DOCUMENT>